These are the positions, trades, and weight of all companies in her ARKK Innovation ETF. More XBI Holdings Current Portfolio Date Nov 20, 2023; Equity Holdings 132; Bond Holdings 0; Other Holdings 3 % Assets in Top 10 Holdings 16. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. To make the peptide traceable, it was radiolabeled with the long. View complete XLP exchange traded fund holdings for better informed ETF trading. The beaten-down prices offer a solid buying opportunity for investors. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 8% of its total assets under management. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at , one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. The top 10 holdings of XBI look like this: XBI Top 10 Holdings (morningstar. 67. Investo S&P Biotech Sel Industry ETF IE. RGLD. Advertisement. Sign Up Log In Dashboard LogoutLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. View Holdings As of 09/30/2023. The top holdings of these ETFs are Exact Sciences Corp. The XBI has been a leader beating other ETFs YTD, up about 35% until today. 50% vs. 01 to $0. 47 and a beta of 0. 06 as the 52 week high point — that compares with a last trade of $109. Region Percentage; North, Central and South America: 99. In trading on Monday the SPDR S&P Biotech ETF is outperforming other ETFs up about 2% on the day. With about 135 holdings, it effectively. 86% so far this year and is down about -32. The Fund's prospectus and statement of additional information dated October 31, 2015, are incorporated by reference into this. 51 on Tuesday. 2% Top Ten Holdings. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. GrowthStrategy: Traditional growth investing is an investment. XBI, whose index recently expanded, also owns only a handful of established biotech companies. S. Meanwhile, XBI equal weights its holdings. In trading on Thursday the Uranium ETF is outperforming other ETFs up about 3. Up vote for PJP but it is pharmaceutical focused and technically not as broad as other biotech ETF's, though the top 10 holdings are comparable. DLTR. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 58%: Halozyme Therapeutics Inc:XLY News. 54%. As can be seen, XBI holds some of the most innovative small-cap biotech companies at equal weight (almost). 01%). In addition to holding 155 positions, its top 10. The fee is slightly higher for SBIO - . 79 as the 52 week high point — that compares with a last trade of $116. In seeking to track the performance of the S&P Biotechnology Select. ARKK ARKG. 96%, and is down about -5. Major Holdings. 40. 64% for the trailing three-year period, making it a high risk. View complete XLV exchange traded fund holdings for better informed ETF trading. Holdings. XBI: SPDR® S&P Biotech ETF: 1. 0. NAV as of Nov 16, 2023. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). 50. 45% and is down about -9. NAV as of Nov 09, 2023. 00. 97. 67. Most recent portfolio value is calculated to be $ 7,141,224,184 USD. 00 (0. In addition to holding 155 positions, its top 10 holdings make up just 14. 88%. Vertex Pharmaceuticals (VRTX 0. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. Check out the side-by-side comparison table of IBB vs. Chart. 12% in the last one year (as of 03/16/2023). Its price to cash flow multiples is about 13. Also I like this style of etf from power shares because the holdings are less weighted in the top two powerhouses (Amgen and Gilead for PJP) than "traditional" ETF's. Twin City Holdings Ltd. "The top five holdings in XBI, as of Dec. 2B. This was a 3 for 1 split, meaning for each share of XBI owned pre-split, the shareholder now owned 3 shares. The top XBI holdings:Glossary: ActiveShareis a measure of the percentage of stock holdings in a manager's portfolio that differ from the benchmark index. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p. NBI IBBQ XBI BTK FBT IBB Other Topics Indexes Stocks ETFs Coronavirus Prableen Bajpai Prableen Bajpai is the founder of FinFix Research and. $7. 38% vs. XBI Holdings (Seeking Alpha) Risks. Holdings. 81 and $97. argenx SE ADR. 46% YTD Daily Total ReturnETF Summary. 0. 95. VHT vs XBI. 28% so far this year and in the past one. Trader's Guide 2024 Ships December 21st. 51. Total net assets. Shares of XBI stock opened at $73. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 78% so far this year and in the past one year (as of 11/20/2023), respectively. XBI, MDGL, SGEN, NTRA: ETF Outflow Alert. 26 during this last 52. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Free ratings, analyses, holdings, benchmarks, quotes, and news. Comparing the most. 00. 45% and is down about -9. Jun 23, 2022 10:49AM EDT. 20. XBI (NYSE Ticker) Summary Prospectus-October 31, 2018. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. Dollar Tree Inc. The ETF return is roughly 4. SPDR S&P Biotech ETF ETF holdings by MarketWatch. According to data from U. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. XBI touched $73. 5%, and a 2. 66%, and is down about -18. XBI vs BBH. Nov 20, 2023Top 10 Holdings. Top 10 Holdings % Portfolio Weight Market Value USD Sector State Street Instl US Govt MMkt Premier 56. Lucy Brewster | Nov 10, 2023. Free ratings, analyses, holdings, benchmarks, quotes, and news. Fund Analysis. Performance and Risk The ETF has lost about -29. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. 58%). 1% which highlights the scope of the fund and diversification away from company-specific risks. As of Oct 31 2023. 60 as the 52 week high point — that compares with a last trade of $70. $156. 84%: Other: 0. 36% of total assets under management. 60%. Compare fees, performance, dividend yield, holdings, technical indicators, and many other metrics to make a better investment decision. XBI. 47% vs -5. 91 Billion . Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Both XBI and XLV are ETFs. XLV comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. Performance and Risk. XBI, TGTX, VKTX, NVAX: Large Outflows Detected at ETF. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. 65%. ETFs are subject to market fluctuation and the risks of their underlying investments. 1. AMGN. Shares of Amgen , IBB's top holding with a weight of 8. Again, top 10 holdings. The index is equal-weighted so that smaller biotech stocks can make it into the portfolio. 35%). XBI has a Diversified Portfolio. 9. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 27%: Number of Holdings 29: Price/Book Ratio Price/Book Ratio. There is no guarantee the funds will achieve their stated investment objectives. Over a longer time than that, it has no top holdings. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. The fund's investments total to approximately $6. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). 44 per share, with $92. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 0. 12% over the last 12 months (as of 07/18/2023). The index and exchange-traded fund ETF are rebalanced four times a year. 67% Top 10 holdings are 16. Holdings: 266: Inception Date: Feb 5, 2001: About IBB Fund Home Page The iShares Biotechnology ETF (IBB) is an exchange-traded fund that is based on the NYSE Biotechnology index. ETFs are subject to market fluctuation and the risks of their underlying investments. Holdings. Find iShares Core High Dividend ETF (HDV) top 10 holdings and sector breakdown by %. All 33 ARKK ETF Holdings. February 15, 2023 — 10:47 am EST. 1 Day NAV Change as of Nov 09, 2023. Immunovant Inc. Message board - Online Community of active, educated investors researching and discussing Novavax Inc. 43. 2 %. 32% of the total portfolio assets. View the latest ETF prices and news for better ETF investing. Also includes news, ETF details and other investing information. 16bn USD. The fund’s NAV was $81. The quantity of holdings in the Fund will be based on a number of factors, including asset size of the Fund. 57 billion. 16bn USD. Seagen Inc Ordinary Shares. Visitors trend 2W 10W 9M. Additionally. 1. 7% of assets. XBI has traded between $62. Viehbacher reported, “In the second quarter, Biogen continued to advance groundbreaking science with the FDA approval of two first-in-class therapies for Alzheimer’s disease and ALS, while also delivering on our. The ETF has lost about -12. Further, the fund owns $6. 08 per unit, that means that analysts see 59. The top 10 concentration is much higher than XBI at 38% given it only has 30 holdings compared to XBI's 140+ holdings. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. Top 10 Holdings (14. 26% rating in the component of Value. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. XBI's top 10 holdings account for about 14. large-cap stocks. During this past 52-week period, the fund has traded between. It can be found in the fund’s most recent prospectus. Holdings. View daily, weekly or monthly formats back to when SPDR S&P Biotech ETF stock was issued. N/A. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. 77. The "A+ Metric Rated ETF" field, available to ETF Database Pro members, highlights the best rated ETF in the Emerging Markets Equities category. 52%. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. XBI focuses on a narrow sector of the health care sector, and as such is probably too precise for most investors. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. Seeking AlphaXBI vs. 27%. BTEK11. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. Neena Mishra May 10, 2023. Meanwhile, XBI equal weights its holdings. 10 as of November 2, 2022. S. 15 per share, with $174. XBI - SPDR® S&P Biotech ETF - Review the XBI stock price, growth, performance,. 66 +2. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Diversification. The XBI index methodology takes market cap and share liquidity into account in rebalancing holdings. The following charts reflect the geographic spread of WCLD's underlying holdings. 81. 73. **Close price adjusted for splits and dividend and/or capital gain distributions. com. High volatility: Small and mid-cap biotech stocks typically exhibit greater price fluctuations, exposing investors to higher levels of market risk and. 26 during this last 52-week period. 16. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. XBI has lost 27. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. The weighted harmonic average of closing market price divided by. Summary From a population of some 350 actively-traded, substantial, and growing ETFs this is a currently attractive addition to a portfolio whose principal objective is wealth accumulation by active investing. This large ETF has performed well and is at its year highs, but will it continue to outperform? With takeover activity occurring in the sector, how will this ETF benefit? How is this ETF. XBI's top 10 holdings account for about 11. The vast majority of XBI holdings have less. Comparing the most. 01 to $0. 23%) Advertisement SPDR S&P Biotech ETF (XBI) NYSEArca - NYSEArca Delayed Price. 2013. It has a total of 153 holdings. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron (REGN). 60 as the 52 week high point — that compares with a last trade of $69. One of the most popular entries among the best biotech ETFs to buy, the SPDR S&P Biotech ETF (NYSEARCA:XBI) benefits from strong volume metrics. We daily evaluate future near-term price gain prospects for quality, market-seasoned ETFs, based on the expectations of market. For XBI holdings in the human health space, I think you also have to account for regulatory and policy risk tied to reimbursement rates for expensive drugs. Analyst Forecast. Complete SPDR S&P Biotech ETF funds overview by Barron's. This is based on the percent of the fund this stock's assets represent. 50 Bil, only including common equities, preferred equities, ETFs, options and warrants for equities. ARGX. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. Below is the comparison between BBH and XBI. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. The weighted harmonic average of closing market price divided by. 01M), Whalerock Point Partners LLC ($343. ETF Channel Staff - Friday, October 20, 6:48 AM. Across the 192 current stocks in the fund, all holdings have a weighting between 0. 46M), Matrix Capital Management Company LP ($188. 86% so far this year and is down about -32. This index comprises companies in the biotech industry that are a part of the S&P Total Market Index. S. 81. Only one of these, AbbVie, is a. 41% so far, and is down about. Staples:. Performance and Risk The ETF has lost about -3. The weighted harmonic average of closing market price divided by. Market Capitalization. The main reason for this is the additional risk mitigation an ETF provides given its myriad holdings within a sector. The equal weight fund, designed to deliver. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. IBB outperformed the S&P 500 last year and did much better than XBI. 7% vs -5. Below is the comparison between BBC and XBI. The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A). 5% position, and no other holding accounts for more than 1. 60 as the 52 week high point — that compares with a last trade of $69. Looking at the chart above, XBI's low point in its 52 week range is $97. View Holdings As of 09/30/2023. The top holding in XBI receives just a 1. 9. 2 %. Holdings; Performance; Risk; Performance Overview-12. 24 per unit, that means that analysts see 75. Below is the comparison between ARKG and XBI. 53 (3. The iShares Core S&P 500 ETF Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of U. Its fund flows were negative $259. 18% and is down about -39. 31 per share, with $92. As of the latest information, Bullfrog AI Holdings will launch its initial public offering ( IPO) — or the first time a private enterprise distributes its equity shares to retail (public. 46% YTD Daily Total Return ETF Summary. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. Assets Under Management. 3. In addition to holding 155 positions, its top 10 holdings make up just 14. 47%. S. 1% which highlights the scope of the fund and diversification away from company-specific risks. Top 10 Holdings. Krane Carbon Cfc (138001) 18. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. View and export this data back to 2006. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Below is the comparison between FBT and XBI. XBI is lower by 45% over the past two years, while the S&P 500 ETF (SPY Quick Quote SPY - Free Report) is higher by 8. com) BioCryst , Biohaven , Exelixis , and AbbVie make up the remainder of the top 5. XBI has a beta of 0. 15 billion. With XBI trading at a recent price near $122. Looking at the chart above, XBI's low point in its 52 week range is $115. 81% of the total fund's. 5. 0. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. Therapeutics Gene Therapy CAR-T Cell Therapy CRSPR Gene Editing. ETF Channel Staff - Friday, October 20, 6:48 AM. Minafi categorizes both of these funds as large funds. 96% vs -5. 7% of assets. 53 (+3. Looking at the chart above, XBI's low point in its 52 week range is $68. Mirati. Track SPDR Biotech ETF (XBI) Stock Price, Quote, latest community messages, chart, news and other stock related information. 64 per share, with $174. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. Looking at the chart above, XBI's low point in its 52 week range is $62. In XBI, the top five holdings together represent only 9. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. So far this year, XBI has lost about -5. The sale of ETFs is subject to an activity assessment fee (from $0. A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security. Last Price Today's Change Today's Volume : Prospectus. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 66738-1. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U. Royal Gold Inc. Looking at the chart above, XBI's low point in its 52 week range is $63. Holdings; Performance; Risk; Performance Overview-12. Year-to-date, the SPDR S&P Biotech ETF has gained about 3. 70% so far this year and is down about -16. View complete XBI exchange traded fund holdings for better informed ETF trading.